Your browser doesn't support javascript.
loading
Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
Wickens, K; Stanley, T V; Mitchell, E A; Barthow, C; Fitzharris, P; Purdie, G; Siebers, R; Black, P N; Crane, J.
Affiliation
  • Wickens K; Wellington Asthma Research Group, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand. kristin.wickens@otago.ac.nz
Clin Exp Allergy ; 43(9): 1048-57, 2013 Sep.
Article in En | MEDLINE | ID: mdl-23957340
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Probiotics / Dietary Supplements / Eczema / Lacticaseibacillus rhamnosus Type of study: Clinical_trials / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Humans / Infant Country/Region as subject: Oceania Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2013 Type: Article Affiliation country: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Probiotics / Dietary Supplements / Eczema / Lacticaseibacillus rhamnosus Type of study: Clinical_trials / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Humans / Infant Country/Region as subject: Oceania Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2013 Type: Article Affiliation country: New Zealand